Imatinib inhibits the malignancy of hepatocellular carcinoma by suppressing autophagy.
Eur J Pharmacol. 2021 Sep 5;906:174217. doi: 10.1016/j.ejphar.2021.174217. Epub 2021 Jun 1.
Eur J Pharmacol. 2021.
PMID: 34087223